Cohn de Laval Award Lectureship

Size: px
Start display at page:

Download "Cohn de Laval Award Lectureship"

Transcription

1 1

2 Cohn de Laval Award Lectureship The Science Behind the Success Development of a Continuous Flow Blood Cell Separator Jeane P Hester, MD Accepted on behalf of Dr Hester and presented by April G Durett, MSc

3 1 st International Congress World Apheresis Association May 20-23, 1986 Tokyo Japan Crown Prince and Princess Takamata 3

4 Chronology Development of Blood Components Need for red blood cells for anemic patients Search for anticoagulants sodium citrate and mechanism of calcium binding Military needs in 2 wars emphasized need for expanding RBC collection and storage Glucose / dextrose added to sodium citrate for RBC metabolism Citric Acid added to reduce K + loss Tullis describes development of Cohn Fractionator resin column removed Ca ++ and platelets allowing passage of RBC and plasma Bierman uses fractionator to deplete leukocytes from a patient Freireich uses single unit leukocytes from CML patients to treat neutropenic infections 4

5 Chronology Development of Blood Components NCI and IBM (Freireich and Judson) development of first continuous flow blood cell separator - IBM 2990 for collection of leukocytes from normal donors Hester and IBM (Kellogg & Mulzet) development next generation continuous flow blood cell separator - IBM 2997 Hester and COBE/BCT development of COBE Spectra continuous flow blood cell separator IBM 2997 at MDACC IBM 2990 / George Judson IBM Archives COBE Spectra 5

6 Design Goals of the First Continuous Flow Cell Separator IBM 2990 Sedimentation in a centrifuge - Leukocytes should be separated from WB at a reasonable efficiency Processing large quantities of blood operation performed on a continuous flow basis Avoid arterial puncture vein-to-vein procedure Anticoagulant that does not require systemic anticoagulation Minimize Platelet, Red Cell and Plasma loss allow processing large volumes of WB from a single donor Entire system should contain 500mL of blood System should allow control by a single operator 6

7 IBM 2990 Bowl Citrated blood enters the bowl, passes vertically to bottom Separated at 850rpm into Packed RBC Leukocyte-platelet rich buffy coat Plasma 3 peristaltic pumps draw separated components to surface for collection or returned to the donor Separate pump infused ACD-A 7

8 Initial Clinical Trials at MDACC Collection of leukocytes from CML patients Provide information on safety and operating effectiveness Potential citrate toxicity Flow rates <50mL per min no adverse events Higher flow rates Parenthesia (face and fingers) Normal ECG QT intervals plasma citrate levels <25-35mg% Decreasing flow rate prompt reversal 8

9 IBM 2990 Used at MDACC Operator controlled pumps Plasma RBC Inlet ACD-A Saline Bowl is mounted in a well 9

10 Relationship between RPM and Leukocyte Separation RPM WBC (E3 per µl) 3,200 1,700 1,500 17, ,000 Relationship established with 2990 Data from CML donors Best separation at low RPM ,000 EJ Freireich, G Judson, and RH Levin Separation and Collection of Leukocytes Cancer Res 25(9) : 1516,

11 Effect of Hematocrit (HCT) on Leukocyte Differential Relationship established with 2990 Data from Normal donors Sample WBC (E3 per µl) MNC (%) PMN (%) HCT (%) 1 7, % 2 16, % 3 12, % 4 13, % 5 3, % EJ Freireich, G Judson, and RH Levin Separation and Collection of Leukocytes Cancer Res 25(9) : 1516,

12 IBM 2997 First unit of the 2997 manufactured was donated to MDACC Apheresis Clinic by IBM 12

13 Disposable channels with Circumferential blood flow Single Stage Dual Stage Collection / Depletion Leukocytes Collection single donor platelets Plasma Exchange Transfusible quantity RBC / Buffy Coat interface stabilized Ready for infusion Jeane P Hester et al, Blood 54(1) : 254,

14 Developments to Improving Granulocyte Yields Hydroxyethyl Starch (HES) Rouleaux formation improved separation of RBC and Granulocytes High molecular weight derivative starch amylopectin Deposition in skin and spleen that possibly led to toxicity Dexamethasone steroid granulocyte mobilizing agent Donors selected from primary family members HLA shared antigens Benefits observed of Granulocyte replacement to neutropenic patients Inability to establish benefits with certainty Limitations in available donors Restrictions in frequency of donation Patient variability uncertainty of response to antibiotics Diversity of pathogenic organisms Duration of neutropenia Currently GCSF increase granulocyte yields Low molecular weight HES shortened excretion time 14

15 Collection of Platelets using Dual Stage Channel Mid 1960s and Early 1970s Pooled units of platelet concentrates from single units whole blood Manual technique involved 2 centrifugation steps Units of packed red blood cells Platelet-poor plasma Platelet concentrates Platelet clumps units left standing until platelets re-suspended Major goal of IBM 2997 perform these steps in continuous process Question : ACD-A flow rate to assure donor safety Question : Citrate concentration in blood being processed to keep platelets in suspension 15

16 ACD-A mg / kg per min Total Citrate mg per min ACD-A Dose Administration to Donors & Patients ACD-A ml / L BV per min Reference CD Bolan et al, Transfusion 42 : 935, S Haddad et al, Transfusion 45 : 934, CD Bolan et al, Transfusion 43 : 1403, CD Bolan et al, Transfusion 41 ; 1165, CD Bolan et al, Transfusion 42 : 935, JP Hester WBC / PLT JP Hester PLT Deplt JP Hester TPE Standard Dose for 2997 & Spectra Calcium replacement Blood Volume estimates H Chaplin & PL Mollison, Blood 7 : 1227,

17 ACD-A Dose Administration to Donors & Patients Standard 1 ml ACD-A per L Blood Volume per min over 90 min procedure Modest increase in citrate 15%-20% reduction Ionized Calcium Symptoms (if present) mild and transient in donors 4.0L TBV Increase ACD-A flow rates ml per L Blood Volume per min Hyopcalcemic symptoms early and more severe Calcium replacement intravenous Calcium Chloride 17

18 Albumin / Globulins 18 Calcium Distribution Ion mm per L % Total Ionized Ca % Protein Bound % Ca-Phosphate % Ca-Citrate % Unidentified Prothrombin Factor X Factor IX Factor VII Factor XI Factor XII Platelets %

19 Calcium Distribution Unstimulated Platelets 8.60 x10 4 high affinity Ca ++ binding sites per platelet 2.89 x10 5 low affinity Ca ++ binding sites per platelet Activated Platelets 1.83 x10 5 new Ca ++ binding sites per platelet Membrane proteins IIb and IIIa for Ca++ dependent complex Ca ++ required for binding of fibrinogen to its receptor Platelet aggregation Presence of Ca ++ and fibrinogen Removal of Ca ++ from surface during mixing with ACD-A inhibits platelet function Calculation of intravasclar platelet pool in a helathy adult 250,000 platelets per µl contains ~10mg Ca ++ 19

20 Citrate Concentration in Whole Blood (WB) Citrate Solution Ratio Citrate : WB mg Citrate per ml WB Apheresis Procedures ACD-A Sodium Citrate (1940s) ACD-A (1950s) Sodium Citrate (PT ) ACD-A + Citric Acid Prothrombin Time Aster et al, J Clin Invest 43 : 843,

21 Citrate Concentration in Whole Blood (WB) Citrate mg per ml Ratio ACD-A : WB % Ca++ Bound ph % % % % % % % Keep Platelets from clumping 1964 Richard Aster lower WB to ph6.5 Jeane Hester proposed ACD-A : WB ratio 6-8 with >2.66mg Citrate per ml 21

22 Binding of Ionized Calcium in Peripheral Blood Related to Citrate Concentration 100% 80% Ionized Calcium Bound 60% 40% 20% 0% Ratios above 1:15 may not bind sufficient calcium to inhibit platelet aggregation and coagulation protein function Ionized Citrate (mg per ml) 22

23 Therapeutic Plasma Exchange Robert Kellogg s mathematical model vs Plasma Bilirubin Levels Kellogg & Hester, Plasma Therapy & Transfusion Technology 8 : 283,1987 Routinely exchanged 1.5x Patient s Plasma Volume Biological marker bilirubin in plasma Patient had undergone partial hepatectomy for a malignancy 23

24 Mobilization from the Extravascular Space Kellogg & Hester, Plasma Therapy & Transfusion Technology 8 : 283,1987 Increase in concentration result of movement from extravascular space to intravascular space following exchange NOT rebound synthesis of pathological molecule 24

25 Therapeutic Plasma Exchange (TPE) Acute Promyelocytic Leukemia Associated with disseminated intravascular coagulopathy and severe hemorrhage TPE to remove multiple procoagulants Fresh Frozen Plasma and Cryoprecipitate replacement fluids Diffuse hemorrhage ceased Rapid rise in plasma fibrinogen concentration Onset of chemotherapy-induced leucopenia Tumor Lysis Syndrome Renal failure avoided with TPE and leukocyte depletion Acute Rhabdomyolisis Renal failure avoided with TPE Acute Respiratory Distress (ARD) Patient with essential thrombocytothemia Onset of pulmonary failure due ARD following surgery for gastric perforation Sudden platelet drop 700,000 per µl to <100,000 in absence of active hemorrhage Consumption process which responded to TPE 25

26 COBE Spectra Principle objective automation of all procedures Creation of algorithms for apheresis procedures Blood is heterogeneous mixture Cell and plasma molecules of various size, density, & function that could influence device performance 26

27 Therapeutic Cytoreduction First Procedure approved for Spectra Nikolai Kalinin, MD collaborator in NIH-Russia Scientific Exchange Program Jeane Hester, MD Patient undergoing platelet reduction 27

28 COBE Spectra Peripheral Blood Stem Cell (PBPC) 1986 PBPC from patients with Multiple Myeloma Bone marrows not used due to infiltration of plasma cells or presence of hypoplasia Chemotherapy mobilization before GCSF and flow cytometric identification of CD34 + cells All patients engrafted earlier than marrow transplants Auto and Allo transplant strategies developed Early 1990s processing bone marrow harvests Objective retain maximum stem cells while reducing volume, erythocte and myeloid fractions Hurdle convince transplant group to use ACD-A instead of heparin >90% mononuclear fraction freshly harvested marrow was retained MNC fraction efficiently collected in aged marrow collected in heparin platelet function lost during transportation 28

29 Collaboration with Professor Peter Jacobs University of Cape Town, South Africa Assisted in establishing Apheresis Unit 1979 obtained COBE Spectra Jeane Hester and Lucille Wood set collection standards Circa 1990 : (back row) Lucille Wood, Professor Jacobs, Dr Hester 29

30 MDACC circa 1990 Apheresis Clinic & Research Laboratory Staff 30

31 What is required in order to advance our knowledge of the natural world is following controlled and systematic procedures. First, we must observe the facts, record our observations and amass a body of reliable data. This is more effectively done by many people working in communication with one another than by individuals working alone hence the need for scientific societies and colleges. At this stage we must be careful not to impose our ideas on the facts, but to let them speak for themselves. When we have amassed enough of them they will begin to do so : regularities and patterns will begin to emerge, casual connections will reveal themselves and we shall start to perceive the laws of nature at work in the particular instances..sir Francis Bacon

Welcome to esessions Operational Principles of Therapeutic Plasma Exchange (TPE) Procedures

Welcome to esessions Operational Principles of Therapeutic Plasma Exchange (TPE) Procedures Welcome to esessions Operational Principles of Therapeutic Plasma Exchange (TPE) Procedures COBE Spectra Apheresis System Presented by CaridianBCT TPE Disposable Tubing Set ACD-A Plasma Plasma Waste Bag

More information

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES TABLE OF CONTENTS SUBJECT PAGE ADULT CRITERIA Red Blood Cells/Autologous 2 Washed Red Blood Cells 2 Cryoprecipitate

More information

Blood Sticky, opaque fluid with a metallic taste (Fe 2+ ) Varies from scarlet (P O2 = 100) to dark red (P O2 = 40) ph is between 7.35 and 7.45 Average volume in an adult is 5 L (7% of body weight) 2 L

More information

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Application Note Primary Cell Analysis Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Cell Viability Introduction: Bone Marrow, Cord Blood, Stem

More information

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions. KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term

More information

Jennifer G. Collins, RN Children s Hospital of Chicago

Jennifer G. Collins, RN Children s Hospital of Chicago Jennifer G. Collins, RN Children s Hospital of Chicago Review the importance of consultation with the stem cell transplant team Review criteria to begin harvest Review ways to modify a harvest procedure

More information

Troubleshooting MNC Collections in the Unmobilized vs Stimulated Donor

Troubleshooting MNC Collections in the Unmobilized vs Stimulated Donor ASFA Annual Meeting Education Session VII: Immuno Therapy in Apheresis May 9, 2015 Troubleshooting MNC Collections in the Unmobilized vs Stimulated Donor Chrissy Anderson, BSN, RN, HP (ASCP) Executive

More information

Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When. Objectives. Sources of Stem Cells

Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When. Objectives. Sources of Stem Cells Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When Objectives Why do need stem cell transplants What type of cells are we using for stem cell transplants When and how we collect peripheral

More information

STEM CELL TRANSPLANTS

STEM CELL TRANSPLANTS UAMS Information on STEM CELL TRANSPLANTS What is a Stem Cell Transplant? A stem cell transplant is an infusion of stem cells following high-dose chemotherapy. The infused cells effectively rescue the

More information

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure

More information

TRANSFUSION MEDICINE

TRANSFUSION MEDICINE TRANSFUSION MEDICINE Transfusion medicine is a one-month per year rotation for a total of three months. During each rotation the resident is exposed to the basic concepts of transfusion medicine. Specific

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Overview of Hematology, http://www.nu.edu.sa/userfiles/mhmorsy/h

More information

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation

More information

Blood-Forming Stem Cell Transplants

Blood-Forming Stem Cell Transplants Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

How To Collect A Leukapheresis Collection

How To Collect A Leukapheresis Collection Leukapheresis Collection Insights in Unstimulated Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving a Combination of Autologous Immunotherapy (AGS-003) and Sunitinib: From the Ongoing

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers

More information

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy ~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 3 of 4 Michael J. Sanfelippo, M.S. Technical Director, Coagulation Services Session 3 Topics Direct Thrombin Inhibitors:

More information

BLOOD GROUP ANTIGENS AND ANTIBODIES

BLOOD GROUP ANTIGENS AND ANTIBODIES BLOOD GROUP ANTIGENS AND ANTIBODIES Over 20 blood group systems having approximately 400 blood group antigens are currently recognised. The ABO and Rhesus (Rh) blood group systems are of major clinical

More information

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding may be spontaneous in the form of small haemorrhages into the

More information

Minimal residual disease detection in Acute Myeloid Leukaemia on a Becton Dickinson flow cytometer

Minimal residual disease detection in Acute Myeloid Leukaemia on a Becton Dickinson flow cytometer Minimal residual disease detection in Acute Myeloid Leukaemia on a Becton Dickinson flow cytometer Purpose This procedure gives instruction on minimal residual disease (MRD) detection in patients with

More information

Transfusion Medicine

Transfusion Medicine Transfusion Medicine Chapter 5 Transfusion Medicine Routine Transfusion Therapy Blood products should not be transfused on a unit basis in children Base the volume of transfusion products on weight to

More information

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012 Disclosures: none The problem:

More information

EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE

EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE Textbook: Skills: None 10 points Objectives: 1. State the principle of the Erythrocytes Sedimentation Rate - ESR. 2. List two factors which may

More information

14.0 Stem Cell Laboratory Services

14.0 Stem Cell Laboratory Services Laboratory Services Contact Information: To inquire about assisting with surgical harvesting of bone marrow, cellular therapy (CT) product processing, cryopreservation, storage, or any other lab services,

More information

STANDARD BLOOD PRODUCTS AND SERVICES

STANDARD BLOOD PRODUCTS AND SERVICES STANDARD BLOOD PRODUCTS AND SERVICES Policy NHP reimburses contracted providers for the medically necessary administration (transfusion) of blood and standard blood products. Prerequisites Authorization,

More information

Acute myeloid leukemia (AML)

Acute myeloid leukemia (AML) Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult

More information

Processing & Utilization of Cord Blood for Transplant

Processing & Utilization of Cord Blood for Transplant Processing & Utilization of Cord Blood for Transplant 2010-Jan Jan-15 Nicole L. Prokopishyn, PhD HPC Processing Laboratory Director Calgary Laboratory Services Overview Cord Blood Processing Pre-Freeze

More information

How To Remove A Drug By Therapeutic Apheresis

How To Remove A Drug By Therapeutic Apheresis Medication Removal by Apheresis Yanyun Wu, M.D., Ph.D. Yale University School of Medicine 1 Objectives Review basic pharmacokinetics and its relevance in drug removal by therapeutic apheresis (TPE) Review

More information

TOTAL PROTEIN FIBRINOGEN

TOTAL PROTEIN FIBRINOGEN UNIT: Proteins 16tproteins.wpd Task Determination of Total Protein, Albumin and Globulins Objectives Upon completion of this exercise, the student will be able to: 1. Explain the ratio of albumin and globulin

More information

Nursing 113. Pharmacology Principles

Nursing 113. Pharmacology Principles Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics

More information

Human Anatomy & Physiology II with Dr. Hubley

Human Anatomy & Physiology II with Dr. Hubley Human Anatomy & Physiology II with Dr. Hubley Exam #1 Name: Instructions This exam consists of 40 multiple-choice questions. Each multiple-choice question answered correctly is worth one point, and the

More information

Automated Cord Blood Processing:

Automated Cord Blood Processing: TM Automated Cord Blood Processing: A Follow-up to the Pilar Solves Study Comparing the AXP vs the Sepax Cord Blood Processing Systems CHRISTY KIM, PETRA CRAVENS, MINDY WILKE-DOUGLAS AND MITCHEL SIVILOTTI

More information

FLUID AND BLOOD THERAPY

FLUID AND BLOOD THERAPY FLUID AND BLOOD THERAPY PURPOSE To familiarize and acquaint the transfer Paramedic with the skills and knowledge necessary to adequately maintain fluid and blood therapy in the interfacility transfer environment

More information

INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS

INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS Sarah Perry, LVT, BS, VTS (ECC) Licensed Veterinary Technician Animal Neurology, Rehabilitation and Emergency Center 1120 Welch Rd. Commerce, MI 48390 A very

More information

Stem Cell Background Paper

Stem Cell Background Paper Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,

More information

ABO-Rh Blood Typing Using Neo/BLOOD

ABO-Rh Blood Typing Using Neo/BLOOD ABO-Rh Blood Typing Using Neo/BLOOD Objectives Determine the ABO and Rh blood type of unknown simulated blood samples. Prepare a simulated blood smear. Examine a prepared blood smear under the microscope

More information

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB

More information

Blood. Blood. Blood Composition. Blood Composition. Fractionation & Hemopoesis

Blood. Blood. Blood Composition. Blood Composition. Fractionation & Hemopoesis Blood Blood Chapter 19 Blood is a specialized fluid connective tissue that contains cells suspended in a fluid matrix Functions of blood include: Transport of dissolved gases, nutrients, hormones and metabolic

More information

Department of Transfusion Medicine and Immunohematology

Department of Transfusion Medicine and Immunohematology Department of Transfusion Medicine and Immunohematology Activities Transfusion medicine is a multidisciplinary area concerned with the proper use of blood and blood components in the treatment of human

More information

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis Blood Objectives Describe the functions of blood Describe blood plasma Explain the functions of red blood cells, white blood cells, and platelets Summarize the process of blood clotting What is Blood?

More information

BLOOD-Chp. Chp.. 6 What are the functions of blood? What is the composition of blood? 3 major types of plasma proteins

BLOOD-Chp. Chp.. 6 What are the functions of blood? What is the composition of blood? 3 major types of plasma proteins 6.1 Blood: An overview BLOOD-Chp Chp.. 6 What are the functions of blood? Transportation: oxygen, nutrients, wastes, carbon dioxide and hormones Defense: against invasion by pathogens Regulatory functions:

More information

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk about

More information

Donating stem cells. What s involved?

Donating stem cells. What s involved? Donating stem cells What s involved? Revised February 2012 The diagnosis of a blood cancer can be a devastating event for patients, families and friends. It is therefore vital for everyone to have access

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

Exercise 9: Blood. Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826.

Exercise 9: Blood. Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826. Exercise 9: Blood Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826. Blood Typing The membranes of human red blood cells (RBCs) contain a variety of cell surface proteins called

More information

SEARCHING FOR A BONE MARROW DONOR

SEARCHING FOR A BONE MARROW DONOR SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need

More information

One of the most important recent developments in cancer treatment has been the ability to harvest stem

One of the most important recent developments in cancer treatment has been the ability to harvest stem BIOTECHNOLOGY A Patient-Friendly Approach to Human Cell Transplantation One of the most important recent developments in cancer treatment has been the ability to harvest stem cells from bone marrow or

More information

Summary of the risk management plan (RMP) for Accofil (filgrastim)

Summary of the risk management plan (RMP) for Accofil (filgrastim) EMA/475472/2014 Summary of the risk management plan (RMP) for Accofil (filgrastim) This is a summary of the risk management plan (RMP) for Accofil, which details the measures to be taken in order to ensure

More information

Date effective: Jan 2005 Date revised: June 2015

Date effective: Jan 2005 Date revised: June 2015 Section H: Administration of Blood Products Page 1 of 8 I. Introduction... 1 II. Intravenous (IV) Access... 2 Peripheral Line:...2 Central Venous Catheter:...2 III. Compatible Solutions with Blood Products...

More information

Cardiovascular System. Blood Components

Cardiovascular System. Blood Components Cardiovascular System Blood Components 1 Components of Blood Formed elements: erythrocytes, leukocytes, platelets Plasma: water, proteins, other solutes The components of blood can be divided into two

More information

RhD typing. Practice for IV year medical students. Zita Csernus MD. National Blood Transfusion Service Blood Transfusion Centre Pécs

RhD typing. Practice for IV year medical students. Zita Csernus MD. National Blood Transfusion Service Blood Transfusion Centre Pécs immunisation Bed side test Antibody tests RhD typing Practice for IV year medical students Zita Csernus MD National Blood Transfusion Service Blood Transfusion Centre Pécs Rh Blood Group System Discovery:

More information

1. BLOOD GROUP SYSTEMS. Page 1. Haematology LECTURE 10. BLOOD GROUPS AND TRANSFUSIONS OVERVIEW. 1. Blood Group Systems

1. BLOOD GROUP SYSTEMS. Page 1. Haematology LECTURE 10. BLOOD GROUPS AND TRANSFUSIONS OVERVIEW. 1. Blood Group Systems Undergraduate Course in Veterinary Clinical PathologySocrates Programme Haematology LECTURE 10. BLOOD GROUPS AND TRANSFUSIONS 10-1 OVERVIEW 1. Blood Group Systems 2. Blood group testing and cross-matching

More information

www.gbo.com/bioscience Tissue Culture 1 Cell/ Microplates 2 HTS- 3 Immunology/ HLA 4 Microbiology/ Bacteriology Purpose Beakers 5 Tubes/Multi-

www.gbo.com/bioscience Tissue Culture 1 Cell/ Microplates 2 HTS- 3 Immunology/ HLA 4 Microbiology/ Bacteriology Purpose Beakers 5 Tubes/Multi- 11 Cryo www.gbo.com/bioscience Technical Information 9 I 2 Leucosep TM 9 I 3 12 ml Leucosep TM Tubes 9 I 3 50 ml Leucosep TM Tubes 9 I 3 Instruction Manual Leucosep TM 9 I 4 OncoQuick 9 I 5 11 Cryo www.gbo.com/bioscience

More information

My Sister s s Keeper. Science Background Talk

My Sister s s Keeper. Science Background Talk My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating

More information

Lupus anticoagulant Pocket card

Lupus anticoagulant Pocket card Lupus anticoagulant Pocket card Issue number 5 2012 Antiphospholipid Syndrome 1 The antiphospholipid syndrome (APS) is diagnosed in patients with recurrent thromboembolic events and /or pregnancy loss

More information

Cord Blood: Thawing & Infusion Practical Methods

Cord Blood: Thawing & Infusion Practical Methods Cord Blood: Thawing & Infusion Practical Methods Donna M Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Objectives Present variety of product configurations

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes

More information

Dr Saeed Al Amoudi. Consultant Hematologist King s college hospital Director of Regional Lab Jeddah

Dr Saeed Al Amoudi. Consultant Hematologist King s college hospital Director of Regional Lab Jeddah Dr Saeed Al Amoudi Consultant Hematologist King s college hospital Director of Regional Lab Jeddah MAGIC BULLET Cord Blood Banking What is Cord Blood? Cord blood is the blood left in the placenta and umbilical

More information

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions.

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions. OBJECTIVES: 1. Describe blood according to its tissue type and major functions. 2. Define the term hematology. 3. Name the average volume of blood in a human. 4. Name the two major components of blood

More information

Contents. Abstract... i. Committee Membership... iii. Foreword... vii. 1 Scope... 1. 2 Introduction... 1. 3 Standard Precautions...

Contents. Abstract... i. Committee Membership... iii. Foreword... vii. 1 Scope... 1. 2 Introduction... 1. 3 Standard Precautions... Vol. 28 No. 20 Replaces H47-A Vol. 16 No. 3 One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline Second Edition This document provides guidelines

More information

Platelet Review July 2012. Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

Platelet Review July 2012. Thomas S. Kickler M.D. Johns Hopkins University School of Medicine Platelet Review July 2012 Thomas S. Kickler M.D. Johns Hopkins University School of Medicine Hemostasis Hemostasis is the process that leads to the stopping of bleeding Hemostasis involves blood vessels,

More information

Platelet Transmission Electron Microscopy and Flow Cytometry 11/15/2015

Platelet Transmission Electron Microscopy and Flow Cytometry 11/15/2015 Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion of current topics and may be helpful to you in your practice. Today our topic looks at hereditary platelet

More information

12.1: The Function of Circulation page 478

12.1: The Function of Circulation page 478 12.1: The Function of Circulation page 478 Key Terms: Circulatory system, heart, blood vessel, blood, open circulatory system, closed circulatory system, pulmonary artery, pulmonary vein, aorta, atrioventricular

More information

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) Protocol Code Tumour Group Contact Physician UGUTIP Genitourinary Dr.

More information

If your doctor has ordered laboratory tests, it s natural

If your doctor has ordered laboratory tests, it s natural A Patient s Guide to Clinical oratory Testing at Kingman Regional Medical Center If your doctor has ordered laboratory tests, it s natural to have questions about why and how the tests are performed. This

More information

How To Save A Patient From A Cancer

How To Save A Patient From A Cancer BIOSTATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH Blood-&-Marrow Transplants & CANCERS Stem Cells Stem cells are immature body cells that act like "starter dough" because they can make identical copies

More information

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including

More information

PREMEDICATIONS: Agent(s) Dose Route Schedule

PREMEDICATIONS: Agent(s) Dose Route Schedule BCCA Protocol Summary for the Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and rituximab Protocol Code Tumour Group

More information

TITLE CLIN_216 HEMODIALYSIS/PLASMAPHERESIS PROCEDURE AND CATHETER MANAGEMENT FOR THE ADULT AND PEDIATRIC PATIENT

TITLE CLIN_216 HEMODIALYSIS/PLASMAPHERESIS PROCEDURE AND CATHETER MANAGEMENT FOR THE ADULT AND PEDIATRIC PATIENT Policies and procedures are guidelines and are not a substitute for the exercise of individual judgment. If you are reading a printed copy of this policy, make sure it is the most current by checking the

More information

Section. 37Renal Dialysis Facility

Section. 37Renal Dialysis Facility Section 37Renal Dialysis Facility 37 37.1 Enrollment...................................................... 37-2 37.1.1 STAR and STAR+PLUS Program Enrollment.......................... 37-2 37.2 Reimbursement..................................................

More information

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation? Infosheet Allogeneic stem cell transplantation in myeloma High-dose therapy and autologous stem cell transplantation is currently the first-line treatment standard of care for younger/fitter myeloma patients.

More information

LIVER FUNCTION TESTS

LIVER FUNCTION TESTS MODULE Liver Function Tests 17 LIVER FUNCTION TESTS 17.1 INTRODUCTION Liver function tests are a group of tests done to assess the functional capacity of the liver as well as any cellular damage to the

More information

Dabigatran (Pradaxa) Guidelines

Dabigatran (Pradaxa) Guidelines Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without

More information

Treating myeloma. Dr Rachel Hall Royal Bournemouth Hospital

Treating myeloma. Dr Rachel Hall Royal Bournemouth Hospital Treating myeloma Dr Rachel Hall Royal Bournemouth Hospital Treatment overview When to treat? Aim of treatment Which treatment? Monitoring response to treatment Prevention of complications What happens

More information

MANUAL PLATELET COUNT

MANUAL PLATELET COUNT MANUAL PLATELET COUNT Principle Whole blood is diluted with a 1% ammonium oxalate solution. The isotonic balance of the diluent is such that all erythrocytes are lysed while the leukocytes, platelets,

More information

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, MD Director, Hemotherapy and Stem Cell Processing Facility E-mail: js2745@columbia.edu A 40-year old man with acute myelogenous

More information

Comparability of Cord Blood Units

Comparability of Cord Blood Units Comparability of Cord Blood Units John D. McMannis,, Ph.D. Professor of Cancer Medicine Director, Cell Therapy Laboratory Technical Director, UT MDAnderson Cord Blood Bank Liaison Meeting, Bethesda June

More information

The 2011 National Blood Collection and Utilization Survey Report

The 2011 National Blood Collection and Utilization Survey Report The 2011 National Blood Collection and Utilization Survey Report The United States Department of Health and Human Services 2011 National Blood Collection and Utilization Survey was conducted under contract

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells

More information

1. To permit the resident to attain expertise in the methodological, diagnostic and scientific aspects of transfusion medicine and coagulation.

1. To permit the resident to attain expertise in the methodological, diagnostic and scientific aspects of transfusion medicine and coagulation. BLOOD BANK CORE ROTATION Introduction The core rotation in blood banking is designed to expose the resident to a wide range of transfusion medicine and coagulation problems and provide training in solving

More information

THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE

THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE FACTS AND FIGURES JUNE 2004 NO 2 THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE Revised Edition Shân Lloyd National Blood Transfusion Service Zimbabwe Published by the World Federation of Hemophilia (WFH);

More information

Name (print) Name (signature) Period. (Total 30 points)

Name (print) Name (signature) Period. (Total 30 points) AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,

More information

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy

More information

Bio 20 Chapter 11 Workbook Blood and the Immune System Ms. Nyboer

Bio 20 Chapter 11 Workbook Blood and the Immune System Ms. Nyboer Bio 20 Chapter 11 Workbook Blood and the Immune System Ms. Nyboer Name: Part A: Components of Blood 1. List the 3 plasma proteins and describe the function of each Albumins osmotic balance Globulins antibodies,

More information

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood Thibodeau: Anatomy and Physiology, 5/e Chapter 17: Blood This chapter begins a new unit. In this unit, the first four chapters deal with transportation one of the body's vital functions. It is important

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Stem Cell Transplantation In Patients with Fanconi Anemia

Stem Cell Transplantation In Patients with Fanconi Anemia Stem Cell Transplantation In Patients with Fanconi Anemia FARF Annual Family Meeting 6/28/15 Casco, ME Parinda A. Mehta, M.D. Cincinnati Children s Hospital Medical Center Improvements in Unrelated Donor

More information

Technical Issues Haematopoetic Progenitor Cells- Apheresis (HPC-A) and Therapeutic T Cell (TC- T) Apheresis Spectra Versus Optia

Technical Issues Haematopoetic Progenitor Cells- Apheresis (HPC-A) and Therapeutic T Cell (TC- T) Apheresis Spectra Versus Optia Technical Issues Haematopoetic Progenitor Cells- Apheresis (HPC-A) and Therapeutic T Cell (TC- T) Apheresis Spectra Versus Optia Senga Taylor Clinical Apheresis Nurse Scottish National Blood Transfusion

More information

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life Recommendations to Transplant Centres Performing Cord Blood Transplants Vicki Antonenas Why Choosing the Right Thaw Method Could Save a Patient s Life Lynn O Donnell (USA) 1 The process of receiving, testing

More information

serum protein and A/ G ratio

serum protein and A/ G ratio serum protein and A/ G ratio Blood plasma contains at least 125 individual proteins. Serum ( as contrasted with plasma) is deficient in those coagulation protein which are consumed during the process of

More information

Please list four delivery functions of blood, two regulatory functions, and two protection functions. Delivery (distribution) functions

Please list four delivery functions of blood, two regulatory functions, and two protection functions. Delivery (distribution) functions Chapter 17 Blood Please list four delivery functions of blood, two regulatory functions, and two protection functions. Delivery (distribution) functions Names Period 1-3 - 2-4 - Regulatory functions 1-2

More information